EU gives CE mark approval to i-cor Synchronized Cardiac Assist System for heart failure- Xenios
Xenios has announced that its i-cor Synchronized Cardiac Assist System has received CE marking and can now be sold in Europe as the world�s first heartbeat-synchronized cardiac assist for cardiogenic shock and high-risk interventions in patients with heart failure. It is not for sale in the US.
The i-cor Synchronized Cardiac Assist System, which uses a miniaturized pump to provide physiological beat-to-beat cardiac assist, is designed to combine myocardial protection with organ perfusion by assisting the weakened heart with synchronized pulses that are superimposed over the patient�s weakened heartbeats. With this ECG-triggered heartbeat i-cor is designed to significantly improve coronary blood flow and limit afterload compared with conventional methods.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
3 mins